CDB-2914: Clinical Trials

4 trials of CDB-2914, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Recruiting 1
Phase 31Completed 1

Follow CDB-2914: new trials by email Literature Review of CDB-2914 trials Research Report on CDB-2914

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mammogram Pretreatment With Ulipristal Acetate
Biospecimen Collection, Magnetic Resonance Imaging, Mammogram - Mammography Screening, Breast Density
Phase 2RecruitingOHSU Knight Cancer Institute262026-08-212026-09-03
Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914
CDB-2914 - Contraception
Phase 2CompletedPopulation Council552008-10-012017-08-15
Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist
CDB-2914 - Leiomyoma
Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)562002-09-022019-12-17
Efficacy Trial of CDB 2914 for Emergency Contraception
CDB-2914, levonorgestrel - Emergency Contraception
Phase 2 / Phase 3CompletedUniversity of Pittsburgh16721999-09-012007-12-17

Conditions studied

Leiomyoma (1)  ·  Myofibroma (1)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  OHSU Knight Cancer Institute (1)  ·  Population Council (1)  ·  University of Pittsburgh (1)

Countries

United States (4)  ·  Chile (1)  ·  Dominican Republic (1)

Top investigators

Abigail Liberty (1)  ·  Diana Blithe, PhD (1)  ·  Lynnette K Nieman, M.D. (1)

Results publications

PMID 17077229, PMID 20881264